Westhovens, R., van Riel, P., Sibilia, J., Vratsanos, G., Nuamah, I., & Becker, J. (2004). Abatacept (CTLA4Ig) treatment increases the remission rate in rheumatoid arthritis patients refractory to methotrexate treatment. BioMed Central.
Citação norma ChicagoWesthovens, R., P. van Riel, J. Sibilia, G. Vratsanos, I. Nuamah, and JC Becker. Abatacept (CTLA4Ig) Treatment Increases the Remission Rate in Rheumatoid Arthritis Patients Refractory to Methotrexate Treatment. BioMed Central, 2004.
Citação norma MLAWesthovens, R., et al. Abatacept (CTLA4Ig) Treatment Increases the Remission Rate in Rheumatoid Arthritis Patients Refractory to Methotrexate Treatment. BioMed Central, 2004.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.